UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

Cell, 2022-02, Vol.185 (4), p.630-640.e10

2022

Volltextzugriff (PDF)

Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy

Cell research, 2017-01, Vol.27 (1), p.151-153

2017

Volltextzugriff (PDF)

The molecular basis for SARS-CoV-2 binding to dog ACE2

Nature communications, 2021-07, Vol.12 (1), p.4195-4195, Article 4195

2021

Volltextzugriff (PDF)

Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1

Cell, 2022-08, Vol.185 (16), p.2952-2960.e10

2022

Volltextzugriff (PDF)

Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species

Cell, 2021-06, Vol.184 (13), p.3438-3451.e10

2021

Volltextzugriff (PDF)

Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3

Immunity (Cambridge, Mass.), 2022-08, Vol.55 (8), p.1501-1514.e3

2022

Volltextzugriff (PDF)

Degradation of the bond performance between composite limestone powder concrete and steel bars under a sulfate freeze–thaw environment

Construction & building materials, 2023-03, Vol.369, p.130515, Article 130515

2023

Volltextzugriff (PDF)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2

Cell discovery, 2020-09, Vol.6 (1), p.68-68, Article 68

2020

Volltextzugriff (PDF)

Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses

Nature communications, 2022-06, Vol.13 (1), p.3547-3547, Article 3547

2022

Volltextzugriff (PDF)

Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health

Biosafety and health, 2022-06, Vol.4 (3), p.147-149

2022

Volltextzugriff (PDF)

Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab

Protein & cell, 2018-01, Vol.9 (1), p.135-139

2018

Volltextzugriff (PDF)

Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency

mBio, 2024-02, Vol.15 (2), p.e0298823-e0298823

2024

Volltextzugriff (PDF)

Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats

PLoS biology, 2019-09, Vol.17 (9), p.e3000436

2019

Volltextzugriff (PDF)

Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7

PLoS pathogens, 2023-09, Vol.19 (9), p.e1011659-e1011659

2023

Volltextzugriff (PDF)

Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants

Nature communications, 2023-07, Vol.14 (1), p.4405-4405, Article 4405

2023

Volltextzugriff (PDF)

Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC

The Journal of immunology (1950), 2017-01, Vol.198 (2), p.873-882

2017

Volltextzugriff (PDF)

Kraft Lignin Electro-Oxidation under Ambient Temperature and Pressure

Energies (Basel), 2023-12, Vol.16 (24), p.8007

2023

Volltextzugriff (PDF)

PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy

Frontiers in immunology, 2022-03, Vol.13, p.826045-826045

2022

Volltextzugriff (PDF)

Divergent Peptide Presentations of HLA-A30 Alleles Revealed by Structures With Pathogen Peptides

Frontiers in immunology, 2019-07, Vol.10, p.1709-1709

2019

Volltextzugriff (PDF)

Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab

Cell reports (Cambridge), 2018-10, Vol.25 (4), p.909-920.e4

2018

Volltextzugriff (PDF)

Seismic Behaviour of Hybrid Precast Shear Walls with Partially Connected Vertically Distributed Reinforcements

Advances in Civil Engineering, 2022-09, Vol.2022 (1)

2022

Volltextzugriff (PDF)

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1

Cell reports (Cambridge), 2024-06, Vol.43 (6), p.114338, Article 114338

2024

Volltextzugriff (PDF)

Crystal clear： visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies

Protein & Cell, 2016-12, Vol.7 (12), p.866-877

2016

Volltextzugriff (PDF)

Human T-cell immunity against the emerging and re-emerging viruses

Science China. Life sciences, 2017-12, Vol.60 (12), p.1307-1316

2017

Volltextzugriff (PDF)

Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses

mBio, 2018-08, Vol.9 (4)

2018

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(75)
Humans
(43)
Animals
(26)
Sars-Cov-2
(23)
Covid-19
(16)
Technology
(16)
Ace2
(15)
Cell Biology
(15)
Severe Acute Respiratory Syndrome Coronavirus 2
(15)
Science & Technology - Other Topics
(14)
Coronaviruses
(13)
Female
(13)
Immunology
(13)
Protein Binding
(13)
Multidisciplinary Sciences
(12)
Angiotensin-Converting Enzyme 2
(11)
Biochemistry & Molecular Biology
(11)
Respiratory System
(11)
Virology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy

The molecular basis for SARS-CoV-2 binding to dog ACE2

Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1

Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species

Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3

Degradation of the bond performance between composite limestone powder concrete and steel bars under a sulfate freeze–thaw environment

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2

Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses

Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health

Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab

Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency

Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats

Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7

Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants

Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC

Kraft Lignin Electro-Oxidation under Ambient Temperature and Pressure

PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy

Divergent Peptide Presentations of HLA-A30 Alleles Revealed by Structures With Pathogen Peptides

Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab

Seismic Behaviour of Hybrid Precast Shear Walls with Partially Connected Vertically Distributed Reinforcements

Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1

Crystal clear： visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies

Human T-cell immunity against the emerging and re-emerging viruses

Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses

Suchergebnisse filtern